Cell Models

Scientists rely on a wide array of cells and organisms as experimental models for research

In vitro human cell line models have been widely used for applications such as toxicology, immunology, and cancer pharmacogenomic studies to predict therapeutic efficacy and to identify novel mechanisms associated with variation in drug response. ATCC advanced cell models such as luciferase-labeled cells, isogenic cells, neural progenitor cells, solute transporter carrier cells, and next-generation cell models will ensure your research results are reproducible and verifiable.

Isogenic Cells

Clinically relevant cell models are critical for studies of molecular and cellular mechanisms of tumors, as well as for drug screening for cancer. Using genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for identifying novel treatment regimens.

Learn More

Luciferase-labeled Cells

Luciferase-labeled cell lines bridge the gap between in vitro and in vivo research for biological mechanism studies and drug development. This advanced model provides a highly sensitive means to measure biological processes in cell-based assays and to assess drug efficacy in live animal models through bioluminescence imaging.

Learn More

Neural Progenitor Cells

Neural Progenitor Cell (NPC) solutions from ATCC are potent models of normal and disease neurobiology and important tools for investigating neural development, degeneration and regeneration, neurogenetics, neural excitability, nervous system disorders, neurotransmitters, neurotoxicity, and drug screening

Learn More

Solute Transporter Carrier Cells

There is growing demand for in vitro kidney transporter models with normal human renal function. By using well-characterized hTERT-immortalized RPTEC's that stably overexpress the OAT1, OCT2, or OAT3 gene, ATCC created kidney cell models that provide renal tissue-relevant results and predictability for clinical trials.

Learn More

Advanced Cancer Models

Advanced culture technologies such as 3-D organoids and conditional reprograming of cells permit the generation and propagation of cancer models that are better able to recapitulate the complexity of human tumors compared with existing cell lines. ATCC offers a growing collection of next-generation 2-D and 3-D patient-derived in vitro cancer models.

Learn More

Organoids

Organoids are capable of long-term expansion in culture while remaining phenotypically and genetically stable. In collaboration with the Human Cancer Models Initiative, we offer primary patient-derived organoids for various tissues, healthy and cancerous, including colon, intestine, stomach, breast, esophagus, lung, liver, prostate, and pancreas.

Learn More